Weekly Recap | Editas Medicine -16.41%, consensus target above spotWeekly Review·1 day ago, 08:10 AMEDIT+1.89%
Weekly Recap | Caris Life Sciences -2.91%, most brokers rate it buyWeekly Review·1 day ago, 07:49 AMCAI+1.25%
Weekly Recap | Twist Bioscience +2%, consensus target below spotWeekly Review·1 day ago, 07:00 AMTWST+0.29%
Weekly Recap | Sellas Life Sciences -16.7%, Friday's heavy-volume slideWeekly Review·1 day ago, 06:47 AMSLS-14.42%
Weekly Recap | Revolution Medicines -2.98%, consensus target above spotWeekly Review·1 day ago, 06:40 AMRVMD+0.21%
Weekly Recap | Regeneron Pharma -5.59%, class action deadline passesWeekly Review·1 day ago, 06:39 AMREGN-1.48%
Weekly Recap | Larimar Therapeutics +2.35%, most brokers rate it buyWeekly Review·1 day ago, 06:12 AMLRMR+1.82%
Weekly Recap | SPDR S&P Biotech -4.65%, most brokers rate it buyWeekly Review·1 day ago, 05:07 AMXBI-0.40%LABD+1.23%
Weekly Recap | LABU.US -13.92%, fading with the biotech complexWeekly Review·1 day ago, 04:33 AMLABU-1.77%
Weekly Recap | Purple Biotech +4.17%, CAPTN-3 patent grantedWeekly Review·Sep 5 at 07:45 AMPPBT-1.15%
